Elmiron® Drug Usage Linked To Vision Impairment

Elmiron® (pentosan polysulfate sodium) is a medication treatment for interstitial cystitis  (painful bladder syndrome). However, recent studies show that patients with long-term exposure to this drug experience unpleasant vision side effects.

Some long term users of Elmiron® develop forms of maculopathy.  The disease affects the central part of the retina in the eye.  The condition advances at a gradual pace and greatly impairs the vision with the possibility of blindness.

Additional eye damage side effects include:

• Eye Pain
• Blurred vision
• Loss vivid color recognition
• Reading trouble
• Line distortion
• Observe dark spots near vision center

The manufacturer of Elmiron®, Janssen Pharmaceuticals, knew about the eye and vision related issues from a clinical trial, but the manufacture opted not to post the eye issues on the warning label. Therefore, the public had no knowledge of the dangerous potential side effects.

Elmiron® lawsuits are now being filed for clients that took the drug over an extended period of time and now have vision impairments.